-
Antibody Phage Display: Overview of a Powerful Technology that Has Quickly Translated to the Clinic
Time of Update: 2021-02-18
A diverse library of recombinant antibodies is generated in this way and can then be exposed or panned on the antigen of interest, typically, this being a molecule associated with a particular pathological condition.
-
Comparative Genomics of the Dictyostelids
Time of Update: 2021-02-18
The proteins predicted to be encoded by the genes in each species have been compared to each other as well as to the complete compilation of nonredundant proteins from bacteria, plants, fungi, and animals.
-
Domestic pd-1 single anti-market competition is fierce, who can be a big winner
Time of Update: 2021-02-18
of the disease or the end of the project (whichever is earlier). According to this scheme, this means that patients who are treated with a single anti-injection solution for reilly can receive a full year's treatment for only five courses, at an annual
-
Misleading and biased: How credible is food and nutrition science research? 【foodaily
Time of Update: 2021-02-18
” An imperfect system Jack Winkler , professor of nutrition policy at Metropolitan University in London, says the biased results from industry-sponsored research institutes are completely credible .
-
COSCO Kansai third-generation nuclear power special anti-corrosion coatings by the national patent
Time of Update: 2021-02-18
cooperation and development agreement for the AP series of nuclear grade coatings, jointly developing nuclear grade anti-corrosion coatings that meet the two types of reactor construction technology, AP1000 and CAP1400, and promoting the domestic
-
China's waterproof industry tycoons gathered karen building materials to visit and study
Time of Update: 2021-02-18
on a field visit Finally, Karen Building Materials Co., Ltd. Chairman Qian Lindi joined 11 other alliance business leaders on strengthening self-discipline and alliance restraint mechanism, deepen quality improvement, carry out fraud insurance
-
Rapid Methods for Detection of MRSA in Clinical Specimens
Time of Update: 2021-02-18
These new methodologies have the advantage of a lower turnaround time than that of traditional culture and susceptibility testing and they are capable of detecting MRSA directly from nasal or wound swabs allowing rapid identification of colonized or infected patients.
-
Bridge paint held the 15th anniversary of the restructuring of the "meritorious staff" recognition conference
Time of Update: 2021-02-18
cadres, section leaders, team leaders and staff backbones from the production, operation, technology and management lines attended the meeting. the "Meritorious Employees" recognition conference is also the company's 15th anniversary celebration
-
Zhuobao Group channel construction road: hand in hand and win-win future
Time of Update: 2021-02-18
China Coatings Network : Zhuobao Technology's construction marketing team throughout the country more than 300 large and medium-sized cities. Over the years of strict norms of training and management, forged a team can recruit good war
-
The new crown vaccine developed in our country is all you care about here
Time of Update: 2021-02-18
: The research team laid out five technical routes such as inactivated vaccine, nucleic acid vaccine, recombinant protein vaccine, adenovirus vector vaccine and detoxifying influenza virus vector vaccine. At present, three vaccines have been
-
Level 3 hospitals should share information throughout the hospital in 2020
Time of Update: 2021-02-18
administrative departments at all levels should continue to improve the overall level of informationization of electronic medical records in the region. By 2019, all three-level hospitals in the jurisdiction should achieve a level 3 or above of the level
-
Japan Functional Food Special (I) | The scale is constantly expanding, and the prevention of living diseases has become a focus
Time of Update: 2021-02-18
of the Consumer Office for permission. Japan Functional Food Classification Diagram This series of topics, Foodaily mainly from the functional label food, analysis of the current situation of the Japanese health food
-
How to create a $100 billion healthy spending trap? Here's the whole story| Dr.Why
Time of Update: 2021-02-18
are good for this important prefix. Vitamin A and night blindness; vitamin D and brown skin disease; vitamin B1 and foot gas disease; vitamin C and sepsis... Important discoveries followed, and in the decades
-
Sword refers to Roche Hessetin! Celltrion/Teva biosimilar Herzuma (Curto bead monoanti) has been approved by the FDA
Time of Update: 2021-02-17
South Korean biopharmaceutical company Celltrion and partner Teva recently announced that the U.S. Food and Drug Administration (FDA) has approved the trastuzumab-pkrb, an anti-biosimilar, for HER2-positive breast cancer treatment.
-
Keytruda reduces the risk of death compared to chemotherapy
Time of Update: 2021-02-17
compared to chemotherapy, Merck's Pembrolizumab was used in patients with advanced esophageal or esophageal gastric junction cancer previously treated with tumors called PD-L1, which reduced the risk of death by 31%. KEYNOTE
-
Non-limiting cancer-type heavy-weight targeted drugs were declared clinically accepted in China
Time of Update: 2021-02-17
, industry news that the company's heavyweight "unlimited cancer" target drug, Vitrakvi, which was bought by Lilly for $8 billion a few days ago, has declared clinical trials (INDs) in China and has been accepted.
-
Forever in short supply of children's medicine: high demand research and development difficult enterprises less
Time of Update: 2021-02-17
policy to encourage research and development, clinical approval and other solutions to the shortage of drugs for children. behind this, there are few domestic clinical trial institutions for children's medicine, higher requirements for clinical
-
Drug market speed-up opportunity: not meeting the scope of clinical needs
Time of Update: 2021-02-17
treatments, the pros and cons of clinical guidelines, and have expert resources in the field of adaptation within the company. are not many teams in the country that can complete the entire process, the high risk of investing in new drugs will still be the root cause of most drug companies' ability to rush to invest in the field.
-
New cancer drugs! The new anti-metabolic compound Lonsurf of Schweija/Dapeng Pharmaceuticals significantly improved survival in the gastric excision subgroup
Time of Update: 2021-02-17
Servier and Taiho Pharmaceutical recently jointly announced that they are evaluating the safety and efficacy of gastric excision groups in TAGS, a global Phase III clinical study of patients treated with metastatic gastric cancer (mGC
-
Breast cancer targeted treatment! Novarce Kisqali performs in patients with incurable visceral metastasis HR-/HER2-advanced breast cancer
Time of Update: 2021-02-17
Swiss pharmaceutical giant Novartis has released subgroup analysis data from three key Phase III MONALEESA studies of the new breast cancer-targeted drug Kisqali. The data showed that in patients with advanced breast cancer 2 negative (HR-/HER2-) pre
